Detection Rate of Serrated Adenomas in Screening Colonoscopy



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:5/25/2018
Start Date:March 20, 2018
End Date:October 2018
Contact:Jenni S Steinbrunner, BS
Email:jenni_steinbrunner@trihealth.com
Phone:513-862-4033

Use our guide to learn which trials are right for you!

Detection Rate of Serrated Adenomas in the Screening Colonoscopy Population

An observational prospective will be conducted to determine the detection rate of serrated
adenoma during screening colonoscopy at our institution. Additionally, the variability of
serrated adenoma detection among endoscopists will be evaluated and the characteristics of
serrated adenomas will be described.

Colonoscopy screening is a preventative measure for colorectal carcinoma (CRC), a highly
malignant and dangerous cancer. Extensive research on the adenoma detection rate has provided
national standards and quality metrics to help assess competence of endoscopists. Currently,
there are no standards established for serrated adenomas. The proposed study would be
conducted at GSH and TriHealth Surgery Center West. This is an observational study and does
not involve any patient interventions. However, because patient healthcare data will be
collected for research, informed consent will be obtained shortly before the procedure. The
main study objective is to determine the detection rate of serrated adenoma during screening
colonoscopy at our institution. Additionally, the variability of serrated adenoma detection
among endoscopists will be evaluated and the characteristics of serrated adenomas will be
described.

Inclusion Criteria:

- Males and females

Exclusion Criteria:

- First degree relative (patient's parent, sibling or child) diagnosed with colorectal
carcinoma at age of 59 or under

- New onset of iron deficiency anemia (within past 3 months)

- Abnormal imaging of colon within past 3 months

- Inadequate visualization reported by endoscopist

- Pregnant women
We found this trial at
1
site
Cincinnati, Ohio 45220
Principal Investigator: Robert Kindel, MD
Phone: 513-862-4033
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials